ALLO - Allogene Therapeutics Announces Q2 Investor Conference Participation | Benzinga
SOUTH SAN FRANCISCO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced that it will participate in four investor conferences in the second quarter of 2024.
Canaccord Genuity Horizons in Oncology Virtual Conference
Monday, April 15, 2024
12:00pm PT/3:00pm ET
JPM Securities Life Sciences Conference
Tuesday, May 14, 2024
6:00am PT/9:00am ET
2024 RBC Capital Markets Global Healthcare Conference
Wednesday, May 15, 2024
8:00am PT/11:00am ET
Goldman Sachs 45th Annual Healthcare Conference
Tuesday, June 11, 2024
5:40am PT/8:40am ET
Any available webcasts will be posted to the Company's website at www.allogene.com under the Investors tab in the News and Events section. Following a live webcast, a replay will be available on the Company's website ...